382 related articles for article (PubMed ID: 31835273)
1. Association between antimicrobial drug class for treatment and retreatment of bovine respiratory disease (BRD) and frequency of resistant BRD pathogen isolation from veterinary diagnostic laboratory samples.
Coetzee JF; Magstadt DR; Sidhu PK; Follett L; Schuler AM; Krull AC; Cooper VL; Engelken TJ; Kleinhenz MD; O'Connor AM
PLoS One; 2019; 14(12):e0219104. PubMed ID: 31835273
[TBL] [Abstract][Full Text] [Related]
2. Prevalence and antimicrobial susceptibility of Mannheimia haemolytica, Pasteurella multocida, and Histophilus somni isolated from the lower respiratory tract of healthy feedlot cattle and those diagnosed with bovine respiratory disease.
Timsit E; Hallewell J; Booker C; Tison N; Amat S; Alexander TW
Vet Microbiol; 2017 Sep; 208():118-125. PubMed ID: 28888626
[TBL] [Abstract][Full Text] [Related]
3. Treatment history and antimicrobial susceptibility results for Mannheimia haemolytica, Pasteurella multocida, and Histophilus somni isolates from bovine respiratory disease cases submitted to the Iowa State University Veterinary Diagnostic Laboratory from 2013 to 2015.
Magstadt DR; Schuler AM; Coetzee JF; Krull AC; O'Connor AM; Cooper VL; Engelken TJ
J Vet Diagn Invest; 2018 Jan; 30(1):99-104. PubMed ID: 29034785
[TBL] [Abstract][Full Text] [Related]
4. Prevalence and temporal trends in antimicrobial resistance of bovine respiratory disease pathogen isolates submitted to the Wisconsin Veterinary Diagnostic Laboratory: 2008-2017.
Holschbach CL; Aulik N; Poulsen K; Ollivett TL
J Dairy Sci; 2020 Oct; 103(10):9464-9472. PubMed ID: 32747101
[TBL] [Abstract][Full Text] [Related]
5. Comparative efficacy of enrofloxacin to that of tulathromycin for the control of bovine respiratory disease and prevalence of antimicrobial resistance in Mannheimia haemolytica in calves at high risk of developing bovine respiratory disease.
Crosby S; Credille B; Giguère S; Berghaus R
J Anim Sci; 2018 Apr; 96(4):1259-1267. PubMed ID: 29471391
[TBL] [Abstract][Full Text] [Related]
6. Limitations of bacterial culture, viral PCR, and tulathromycin susceptibility from upper respiratory tract samples in predicting clinical outcome of tulathromycin control or treatment of bovine respiratory disease in high-risk feeder heifers.
Sarchet JJ; Pollreisz JP; Bechtol DT; Blanding MR; Saltman RL; Taube PC
PLoS One; 2022; 17(2):e0247213. PubMed ID: 35143504
[TBL] [Abstract][Full Text] [Related]
7. A ten-year (2000-2009) study of antimicrobial susceptibility of bacteria that cause bovine respiratory disease complex--Mannheimia haemolytica, Pasteurella multocida, and Histophilus somni--in the United States and Canada.
Portis E; Lindeman C; Johansen L; Stoltman G
J Vet Diagn Invest; 2012 Sep; 24(5):932-44. PubMed ID: 22914822
[TBL] [Abstract][Full Text] [Related]
8. Association between antimicrobial drug class selection for treatment and retreatment of bovine respiratory disease and health, performance, and carcass quality outcomes in feedlot cattle.
Coetzee JF; Cernicchiaro N; Sidhu PK; Kleinhenz MD
J Anim Sci; 2020 Apr; 98(4):. PubMed ID: 32255182
[TBL] [Abstract][Full Text] [Related]
9. A literature review of antimicrobial resistance in Pathogens associated with bovine respiratory disease.
DeDonder KD; Apley MD
Anim Health Res Rev; 2015 Dec; 16(2):125-34. PubMed ID: 26373635
[TBL] [Abstract][Full Text] [Related]
10. In vitro activities of tulathromycin and ceftiofur combined with other antimicrobial agents using bovine Pasteurella multocida and Mannheimia haemolytica isolates.
Sweeney MT; Brumbaugh GW; Watts JL
Vet Ther; 2008; 9(3):212-22. PubMed ID: 19003782
[TBL] [Abstract][Full Text] [Related]
11. Multidrug resistant Mannheimia haemolytica isolated from high-risk beef stocker cattle after antimicrobial metaphylaxis and treatment for bovine respiratory disease.
Woolums AR; Karisch BB; Frye JG; Epperson W; Smith DR; Blanton J; Austin F; Kaplan R; Hiott L; Woodley T; Gupta SK; Jackson CR; McClelland M
Vet Microbiol; 2018 Jul; 221():143-152. PubMed ID: 29981701
[TBL] [Abstract][Full Text] [Related]
12. Comparative minimum inhibitory and mutant prevention drug concentrations of enrofloxacin, ceftiofur, florfenicol, tilmicosin and tulathromycin against bovine clinical isolates of Mannheimia haemolytica.
Blondeau JM; Borsos S; Blondeau LD; Blondeau BJ; Hesje CE
Vet Microbiol; 2012 Nov; 160(1-2):85-90. PubMed ID: 22677482
[TBL] [Abstract][Full Text] [Related]
13. Antimicrobial resistance in bovine respiratory disease: Auction market- and ranch-raised calves.
Wennekamp TR; Waldner CL; Windeyer MC; Larson K; Trokhymchuk A; Campbell JR
Can Vet J; 2022 Jan; 63(1):47-54. PubMed ID: 34975167
[TBL] [Abstract][Full Text] [Related]
14. Mannheimia haemolytica and Pasteurella multocida in Bovine Respiratory Disease: How Are They Changing in Response to Efforts to Control Them?
Snyder E; Credille B
Vet Clin North Am Food Anim Pract; 2020 Jul; 36(2):253-268. PubMed ID: 32327253
[TBL] [Abstract][Full Text] [Related]
15. New interpretive criteria for danofloxacin antibacterial susceptibility testing against Mannheimia haemolytica and Pasteurella multocida associated with bovine respiratory disease.
Sweeney MT; Papich MG; Watts JL
J Vet Diagn Invest; 2017 Mar; 29(2):224-227. PubMed ID: 28064562
[TBL] [Abstract][Full Text] [Related]
16. In-vitro antibiotic resistance phenotypes of respiratory and enteric bacterial isolates from weaned dairy heifers in California.
Depenbrock S; Aly S; Wenz J; Williams D; ElAshmawy W; Clothier K; Fritz H; McArthur G; Heller M; Chigerwe M
PLoS One; 2021; 16(11):e0260292. PubMed ID: 34818352
[TBL] [Abstract][Full Text] [Related]
17. Prevalence and antimicrobial resistance of opportunistic pathogens associated with bovine respiratory disease isolated from nasopharyngeal swabs of veal calves in Switzerland.
Schönecker L; Schnyder P; Schüpbach-Regula G; Meylan M; Overesch G
Prev Vet Med; 2020 Dec; 185():105182. PubMed ID: 33152661
[TBL] [Abstract][Full Text] [Related]
18. Relationship of in vitro minimum inhibitory concentrations of tilmicosin against Mannheimia haemolytica and Pasteurella multocida and in vivo tilmicosin treatment outcome among calves with signs of bovine respiratory disease.
McClary DG; Loneragan GH; Shryock TR; Carter BL; Guthrie CA; Corbin MJ; Mechor GD
J Am Vet Med Assoc; 2011 Jul; 239(1):129-35. PubMed ID: 21718206
[TBL] [Abstract][Full Text] [Related]
19. Isolation and antimicrobial susceptibilities of bacterial pathogens from bovine pneumonia: 1994--2002.
Welsh RD; Dye LB; Payton ME; Confer AW
J Vet Diagn Invest; 2004 Sep; 16(5):426-31. PubMed ID: 15460326
[TBL] [Abstract][Full Text] [Related]
20. Antimicrobial susceptibility patterns and sensitivity to tulathromycin in goat respiratory bacterial isolates.
Clothier KA; Kinyon JM; Griffith RW
Vet Microbiol; 2012 Apr; 156(1-2):178-82. PubMed ID: 22078276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
